Stockreport

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024

Lumos Pharma, Inc.  (LUMO) 
PDF AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare disease [Read more]